Leukocyte surface biomarkers implicate deficits of innate immunity in sporadic Alzheimer's disease.

Alzheimer's disease CD11c CD163 CD59 CD91 ROC curve complement system innate phagocytosis leukocyte biomarker peripheral immune response receptor for advanced glycation end products (RAGE)

Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
05 2023
Historique:
revised: 24 08 2022
received: 29 03 2022
accepted: 02 09 2022
pmc-release: 01 05 2024
medline: 15 5 2023
pubmed: 10 11 2022
entrez: 9 11 2022
Statut: ppublish

Résumé

Blood-based diagnostics and prognostics in sporadic Alzheimer's disease (AD) are important for identifying at-risk individuals for therapeutic interventions. In three stages, a total of 34 leukocyte antigens were examined by flow cytometry immunophenotyping. Data were analyzed by logistic regression and receiver operating characteristic (ROC) analyses. We identified leukocyte markers differentially expressed in the patients with AD. Pathway analysis revealed a complex network involving upregulation of complement inhibition and downregulation of cargo receptor activity and Aβ clearance. A proposed panel including four leukocyte markers - CD11c, CD59, CD91, and CD163 - predicts patients' PET Aβ status with an area under the curve (AUC) of 0.93 (0.88 to 0.97). CD163 was the top performer in preclinical models. These findings have been validated in two independent cohorts. Our finding of changes on peripheral leukocyte surface antigens in AD implicates the deficit in innate immunity. Leukocyte-based biomarkers prove to be both sensitive and practical for AD screening and diagnosis.

Identifiants

pubmed: 36349985
doi: 10.1002/alz.12813
pmc: PMC10166765
mid: NIHMS1840176
doi:

Substances chimiques

Amyloid beta-Peptides 0
Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2084-2094

Subventions

Organisme : NIA NIH HHS
ID : R01 AG058252
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062429
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG051848
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG010483
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG073979
Pays : United States
Organisme : NIA NIH HHS
ID : U24 AG057437
Pays : United States

Informations de copyright

© 2022 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

Références

Nat Genet. 2011 May;43(5):436-41
pubmed: 21460841
J Intern Med. 2017 Aug;282(2):116-128
pubmed: 28345259
Nat Immunol. 2010 Feb;11(2):155-61
pubmed: 20037584
Expert Rev Neurother. 2009 Nov;9(11):1623-33
pubmed: 19903022
EMBO J. 2004 Oct 13;23(20):4096-105
pubmed: 15457210
J Alzheimers Dis Rep. 2021 Jun 03;5(1):443-468
pubmed: 34368630
Alzheimers Dement. 2016 Mar;12(3):292-323
pubmed: 27012484
Genome Med. 2018 Feb 26;10(1):14
pubmed: 29482603
Lancet. 2016 Jul 30;388(10043):505-17
pubmed: 26921134
Sci Adv. 2020 Nov 25;6(48):
pubmed: 33239300
Alzheimers Dement. 2011 May;7(3):280-92
pubmed: 21514248
Brain. 2013 Nov;136(Pt 11):3427-40
pubmed: 24088808
J Biol Chem. 1993 Jun 5;268(16):11811-6
pubmed: 7685021
Nature. 2016 Apr 14;532(7598):240-244
pubmed: 27049947
Nat Genet. 2000 Nov;26(3):270-1
pubmed: 11062461
Cell. 1995 Jul 28;82(2):331-40
pubmed: 7543026
Nat Med. 2016 Feb;22(2):135-7
pubmed: 26779813
Neurology. 1998 Jun;50(6):1905-7
pubmed: 9633759
Nat Med. 2003 Jul;9(7):907-13
pubmed: 12808450
Nat Commun. 2013;4:2030
pubmed: 23799536
Nat Rev Neurol. 2017 Sep 29;13(10):612-623
pubmed: 28960209
Nature. 2018 Feb 8;554(7691):249-254
pubmed: 29420472
Alzheimers Dement. 2022 Jan;18(1):88-102
pubmed: 34032364
JAMA Neurol. 2020 Jun 1;77(6):735-745
pubmed: 32250387
Alzheimers Dement (Amst). 2019 Jun 28;11:483-492
pubmed: 31334328
Neurosci Lett. 1997 Feb 7;222(3):187-90
pubmed: 9148246
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Nat Genet. 2009 Oct;41(10):1094-9
pubmed: 19734903
Neurosci Lett. 1998 May 8;247(1):33-6
pubmed: 9637403
Neurology. 2016 Aug 2;87(5):539-47
pubmed: 27371494

Auteurs

Xin Huang (X)

The Florey Institute of Neuroscience, the University of Melbourne, Parkville, Victoria, Australia.

Yihan Li (Y)

The Florey Institute of Neuroscience, the University of Melbourne, Parkville, Victoria, Australia.

Christopher Fowler (C)

The Florey Institute of Neuroscience, the University of Melbourne, Parkville, Victoria, Australia.

James D Doecke (JD)

The Australian e-Health Research Centre, CSIRO, Brisbane, Queensland, Australia.

Yen Ying Lim (YY)

Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria, Australia.

Candace Drysdale (C)

The Florey Institute of Neuroscience, the University of Melbourne, Parkville, Victoria, Australia.

Vicky Zhang (V)

The Florey Institute of Neuroscience, the University of Melbourne, Parkville, Victoria, Australia.

Keunha Park (K)

The Florey Institute of Neuroscience, the University of Melbourne, Parkville, Victoria, Australia.

Brett Trounson (B)

The Florey Institute of Neuroscience, the University of Melbourne, Parkville, Victoria, Australia.

Kelly Pertile (K)

The Florey Institute of Neuroscience, the University of Melbourne, Parkville, Victoria, Australia.

Rebecca Rumble (R)

The Florey Institute of Neuroscience, the University of Melbourne, Parkville, Victoria, Australia.

John W Pickering (JW)

Department of Medicine, University of Otago, New Zealand and Department of Emergency Medicine, Christchurch Hospital, Christchurch, New Zealand.

Robert A Rissman (RA)

Department of Neurosciences, University of California, San Diego, California, USA.

Floyd Sarsoza (F)

Department of Neurosciences, University of California, San Diego, California, USA.

Sara Abdel-Latif (S)

Alzheimer's Therapeutic Research Institute, University of Southern California, San Diego, California, USA.

Yong Lin (Y)

National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China.

Vincent Doré (V)

The Australian e-Health Research Centre, CSIRO, Brisbane, Queensland, Australia.
Department of Molecular Imaging & Therapy, Austin Health, Melbourne, Australia, and Department of Medicine, the University of Melbourne, Melbourne, Australia.

Victor Villemagne (V)

Department of Molecular Imaging & Therapy, Austin Health, Melbourne, Australia, and Department of Medicine, the University of Melbourne, Melbourne, Australia.

Christopher C Rowe (CC)

Department of Molecular Imaging & Therapy, Austin Health, Melbourne, Australia, and Department of Medicine, the University of Melbourne, Melbourne, Australia.

Jurgen Fripp (J)

The Australian e-Health Research Centre, CSIRO, Brisbane, Queensland, Australia.

Ralph Martins (R)

Centre of Excellence for Alzheimer's Disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.

James S Wiley (JS)

The Florey Institute of Neuroscience, the University of Melbourne, Parkville, Victoria, Australia.

Paul Maruff (P)

The Florey Institute of Neuroscience, the University of Melbourne, Parkville, Victoria, Australia.
CogState Ltd., Melbourne, Victoria, Australia.

Jacobo E Mintzer (JE)

NeuroQuest, Inc., Medical University of South Carolina, South Carolina, USA.

Colin L Masters (CL)

The Florey Institute of Neuroscience, the University of Melbourne, Parkville, Victoria, Australia.

Ben J Gu (BJ)

The Florey Institute of Neuroscience, the University of Melbourne, Parkville, Victoria, Australia.
National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH